Bafna Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE878I01022
  • NSEID: BAFNAPH
  • BSEID: 532989
INR
160.19
5.83 (3.78%)
BSENSE

Jun 19, 03:30 PM

BSE+NSE Vol: 33.89 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 852453,
    "name": "Bafna Pharma.",
    "stock_name": "Bafna Pharma.",
    "full_name": "Bafna Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/bafna-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "160.19",
    "chg": 5.83,
    "chgp": "3.78%",
    "dir": 1,
    "prev_price": "154.36",
    "mcapval": "388.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532989,
    "symbol": "BAFNAPH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE878I01022",
    "curr_date": "Jun 19, 03:30 PM",
    "curr_time": "04:33 AM",
    "last_traded_at": "Jun 19, 03:30 PM IST",
    "bse_nse_vol": "33.89 k",
    "exc_status": "Active",
    "traded_date": "Jun 19, 2026",
    "traded_date_str": "2026 06 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bafna-pharma-852453-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bafna Pharmaceuticals Falls 1.74% Despite Volatile Week Marked by Circuit Limits",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-falls-174-despite-volatile-week-marked-by-circuit-limits-4065515",
        "imagepath": "",
        "date": "2026-06-20 15:00:41",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>15 Jun:</strong> Lower circuit hit amid heavy selling (Rs.157.18)</p>\n                    <p><strong>16 Jun:</strong> Locked lower circuit for second consecutive day (Rs.149.33)</p>\n                    <p><strong>17 Jun:</strong> Upper circuit surge reversing downtrend (Rs.156.79)</p>\n                    <p><strong>19 Jun:</strong> Another upper circuit close amid strong buying (Rs.162.07)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.166.25</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-..."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-4063452",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_stocks_hitting_upper_circuit_4063452.png",
        "date": "2026-06-19 12:00:09",
        "description": "At Rs 162.07, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5% on 19 Jun 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-4058674",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_stocks_hitting_upper_circuit_4058674.png",
        "date": "2026-06-17 10:00:56",
        "description": "At Rs 156.79, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5.0% on 17 Jun 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 4.99% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4055720",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_stocks_hitting_lower_circuit_4055720.png",
        "date": "2026-06-16 10:00:16",
        "description": "At Rs 149.33, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 4.99% on 16 Jun 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4054491",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_stocks_hitting_lower_circuit_4054491.png",
        "date": "2026-06-15 13:00:10",
        "description": "At Rs 157.18, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 5.0% on 15 Jun 2026, with unfilled sell orders and a frozen price, signalling a pronounced imbalance between supply and demand in this micro-cap stock."
      },
      {
        "title": "Bafna Pharmaceuticals Gains 33.40%: 5 Key Factors Driving the Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-gains-3340-5-key-factors-driving-the-surge-4052173",
        "imagepath": "",
        "date": "2026-06-13 17:04:13",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Upper circuit hit at Rs.140.45 (+4.81%)</p>\n                    <p><strong>2 June:</strong> Upper circuit hit again, closing at Rs.147.45 (+4.98%)</p>\n                    <p><strong>3 June:</strong> Third consecutive upper circuit at Rs.154.80 (+4.98%) and valuation downgrade noted</p>\n                    <p><strong>4 June:</strong> Fourth upper circuit day, closing at Rs.162.50 (+4.97%)</p>\n                    <p><strong>5 June:</strong> Fifth day surge with a 10.00% gain, closing at Rs.178.75</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value..."
      },
      {
        "title": "Bafna Pharmaceuticals Drops 6.99%: 7 Key Events Shaping the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-drops-699-7-key-events-shaping-the-week-4051237",
        "imagepath": "",
        "date": "2026-06-13 12:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>8 Jun:</strong> Upper circuit hit at Rs.196.60 (+9.99%) amid strong buying momentum</p>\n                    <p><strong>9 Jun:</strong> New 52-week high at Rs.215.7 and second upper circuit close at Rs.176.95 (-9.99%)</p>\n                    <p><strong>10 Jun:</strong> Golden Cross formation; stock hits lower circuit at Rs.165.86 (-4.97%)</p>\n                    <p><strong>11 Jun:</strong> Lower circuit hit again at Rs.157.57 (-5.0%) amid heavy selling</p>\n                    <p><strong>12 Jun:</strong> Week closes with third lower circuit at Rs.166.25 (-4.97%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=..."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4048710",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_stocks_hitting_lower_circuit_4048710.png",
        "date": "2026-06-12 10:00:14",
        "description": "At Rs 165.45, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 5.0% on 12 Jun 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4046290",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_stocks_hitting_lower_circuit_4046290.png",
        "date": "2026-06-11 10:00:22",
        "description": "At Rs 157.57, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 5.0% on 11 Jun 2026, with unfilled sell orders and a frozen price, signalling a day dominated by supply overwhelming demand."
      }
    ],
    "total": 337,
    "sid": "852453",
    "stock_news_url": "https://www.marketsmojo.com/news/bafna-pharmaceuticals-852453"
  },
  "announcements": [
    {
      "details": "Bafna Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 13, 2019.",
      "source": "NSE",
      "caption": "Bafna Pharmaceuticals Limited - Outcome of Board Meeting",
      "datetime": "14-Nov-2019"
    },
    {
      "details": " <table><tr><td>The Exchange had sought clarification from Bafna Pharmaceuticals Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed. </td></tr></table>",
      "source": "NSE",
      "caption": "Reply to Clarification- Financial results",
      "datetime": "27-Aug-2019"
    },
    {
      "details": " <table><tr><td>BAFNAPHARM: Members of the Exchange are hereby informed that the trading in Equity Shares of Bafna Pharmaceuticals Limited shall be suspended w.e.f. August 26, 2019 (i.e. closing hours of trading on August 23, 2019) on account of Reduction of Share Capital. </td></tr></table>",
      "source": "NSE",
      "caption": "Suspension of trading in equity shares",
      "datetime": "21-Aug-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bafna Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 19 Sep 13",
          "dt": "2013-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Bafna Pharmaceuticals Falls 1.74% Despite Volatile Week Marked by Circuit Limits

2026-06-20 15:00:41

Key Events This Week

15 Jun: Lower circuit hit amid heavy selling (Rs.157.18)

16 Jun: Locked lower circuit for second consecutive day (Rs.149.33)

17 Jun: Upper circuit surge reversing downtrend (Rs.156.79)

19 Jun: Another upper circuit close amid strong buying (Rs.162.07)

Bafna Pharmaceuticals Gains 33.40%: 5 Key Factors Driving the Surge

2026-06-13 17:04:13

Key Events This Week

1 June: Upper circuit hit at Rs.140.45 (+4.81%)

2 June: Upper circuit hit again, closing at Rs.147.45 (+4.98%)

3 June: Third consecutive upper circuit at Rs.154.80 (+4.98%) and valuation downgrade noted

4 June: Fourth upper circuit day, closing at Rs.162.50 (+4.97%)

5 June: Fifth day surge with a 10.00% gain, closing at Rs.178.75

stock-recommendationAnnouncement

Bafna Pharmaceuticals Limited - Outcome of Board Meeting

14-Nov-2019 | Source : NSE

Bafna Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 13, 2019.

Reply to Clarification- Financial results

27-Aug-2019 | Source : NSE

The Exchange had sought clarification from Bafna Pharmaceuticals Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed.

Suspension of trading in equity shares

21-Aug-2019 | Source : NSE

BAFNAPHARM: Members of the Exchange are hereby informed that the trading in Equity Shares of Bafna Pharmaceuticals Limited shall be suspended w.e.f. August 26, 2019 (i.e. closing hours of trading on August 23, 2019) on account of Reduction of Share Capital.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Bafna Pharmaceuticals Ltd has declared 6% dividend, ex-date: 19 Sep 13

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available